Stockreport

New Analyses from the Phase 3 HELP Study™ Open-Label Extension in Hereditary Angioedema Evaluate Efficacy and Safety of TAKHZYRO® (lanadelumab-flyo) Injection During Extended Study Treatme...

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Data Presented at the 2019 American College of Allergy, Asthma and Immunology Annual Meeting OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TS [Read more]